Eventide Asset Management, LLC Solid Biosciences Inc. Transaction History

Eventide Asset Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$3.49 - $5.51 $3.78 Million - $5.96 Million	-1,081,868 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$5.37 - $10.72 $5.81 Million - $11.6 Million	1,081,868 New	1,081,868 $5.98 Million
Q4 2018 Feb 14, 2019	SELL	$21.32 - $46.34 $8.53 Million - $18.5 Million	-400,000 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$7.19 - $33.17 $2.88 Million - $13.3 Million	400,000 New	400,000 $3 Million

Ticker SLDB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 7,533,080
Market Cap $30.4M
Description
Solid Biosciences Inc. engages in developing therapies for duchenne muscular dystrophy in the United States. The company's lead product candidate is SGT-001, a gene transfer candidate, which is in a Phase I/II clinical trial to drive functional dystrophin protein expression in patients' muscles; and SGT-003, a ext-generation gene transfer candid...

Get notified when there are updates to the investment portfolio of Eventide Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Eventide Asset Management, LLC with notifications on news.